Company / EPS (Diluted)
PLIANT THERAPEUTICS, INC. EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$3.47
FY2025
5-year range
-$4.22 / -$2.71
FY2021-FY2025
Trend
-18.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-2.71 to $-3.47 over the past 2 years.
Based on SEC 10-K filings.
-3.47 in FY2025.
Declined from $-2.71 to $-3.47 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 18.0% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.47 | -18.0% |
| FY2024 | -$2.94 | -8.5% |
| FY2023 | -$2.71 | +0.0% |
| FY2022 | -$2.71 | +35.8% |
| FY2021 | -$4.22 | +0.0% |
| FY2020 | -$4.22 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026